The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

The pharmaceutical lobby is ramping up its opposition to nonprofit health systems’ expanding use of the 340B Drug Discount ...

Trump is correct to seek to lower drug prices, but price controls will leave Americans with less choices without addressing ...

The 340B program started its massive expansion in 2010 when more entities became eligible; also, in that same year, covered entities were allowed to develop business relationships with off-site ...

New York hospitals that participate in 340B should be required to publicly report how much revenue they generate from the ...

Validate that patient eligibility is assessed prior to dispensing 340B program drugs. Validate that the pharmacy inventory management system is tracking 340B program drugs.

Created in 1992, the 340B Drug Pricing Program is a U.S. federal government program intended to give safety net providers—those that organize and deliver a significant level of both healthcare ...

Many rely on the federal 340B Drug Pricing Program, which allows eligible healthcare providers to purchase outpatient medications at reduced prices.

Discover how the 340B drug pricing program, intended to help low-income patients, has become a system of abuse and misuse without government oversight.

Some 340B-eligible hospitals pocket the program savings instead of passing them on to patients, while pharmacy benefit managers and major pharmacy chains take their own cut.

Johnson & Johnson is backing down from using its planned rebate model in the 340B program. In a September 30 letter to the Health Resource and Services Administration, J&J said it would not implement ...